Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens

  • First published: 18 January 2022
  • Last modified: 18 January 2022
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security
Authority ID:
AA81939
Publication date:
18 January 2022
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Mass testing using lateral flow testing kits (LFTs) for the detection of Covid-19 viral antigens has become a key part of protecting the economy and saving lives during the Covid-19 pandemic. UKHSA has ensured the supply of LFTs by implementing a Dynamic Purchasing System (as advertised in a contract notice on the Find a Tender Service with reference C22033 on 5 March 2021). Further to that DPS, UKHSA published an Invitation to Tender on 27 July 2021 with reference C40441 for the supply of up to 600 million LTFs in packs of 7. This tender concluded and contracts were awarded in September 2021. <br/>The Omicron outbreak and its high transmissibility, which was not foreseeable by UKHSA, has led to a significant and urgent surge in demand for LFTs. As a result, it was necessary to fully utilise the supply of LFTs available under tender C40441 and then increase the volume of LFTs available under that tender to 713,500,000. This was necessary to ensure continuing supply of LFTs to the public, as any delay would risk the current stock of LFTs being exhausted thereby introducing a significant risk to public health. This modification (in the form of increased volume available under the tender) does not alter the overall nature of the contracts let under the tender process. <br/>In accordance with the allocation mechanism set out in the ITT, and following this modification, UKHSA entered into a contract with Innova Medical Group Inc on 17 December 2021 for the supply of LFTs. This order was made up of volume anticipated under the original tender as well as additional volume available as a result of this modification. The total value of both elements was £322,500,000. The increase in price as a result of the modification does not exceed 50% of the value of the original contracts let under the original tender process.<br/>No further tender process was required to implement this modification because it meets the requirements set out in Regulation 72(1)(c) of the Public Contracts Regulations 2015 for the reasons set out in this notice.

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency

Nobel House, 17 Smith Square

London

SW1P 3JR

UK

Contact person: Procurement Operations

E-mail: Procurement.operations@dhsc.gov.uk

NUTS: UKI32

Internet address(es)

Main address: https://www.gov.uk/government/organisations/uk-health-security-agency

Address of the buyer profile: https://www.gov.uk/government/organisations/uk-health-security-agency

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Provision of Lateral Flow testing devices for the detection of COVID-19 viral antigens

II.1.2) Main CPV code

33141625

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

Mass testing using lateral flow testing kits (LFTs) for the detection of Covid-19 viral antigens has become a key part of protecting the economy and saving lives during the Covid-19 pandemic. The Omicron outbreak and its high transmissibility, which was not foreseeable by UKHSA, has led to a significant and urgent surge in demand for LFTs. As a result, it was necessary to fully utilise the supply of LFTs available under tender C40441 and then increase the volume of LFTs available under that tender. In accordance with the allocation mechanism set out in the ITT, and following this modification, UKHSA entered into a contract with Innova Medical Group Inc on 17 December 2021 for the supply of LFTs.

II.1.6) Information about lots

This contract is divided into lots: No

II.1.7) Total value of the procurement

Value excluding VAT: 322 500 000.00  GBP

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Mass testing using lateral flow testing kits (LFTs) for the detection of Covid-19 viral antigens has become a key part of protecting the economy and saving lives during the Covid-19 pandemic. UKHSA has ensured the supply of LFTs by implementing a Dynamic Purchasing System (as advertised in a contract notice on the Find a Tender Service with reference C22033 on 5 March 2021). Further to that DPS, UKHSA published an Invitation to Tender on 27 July 2021 with reference C40441 for the supply of up to 600 million LTFs in packs of 7. This tender concluded and contracts were awarded in September 2021. <br/>The Omicron outbreak and its high transmissibility, which was not foreseeable by UKHSA, has led to a significant and urgent surge in demand for LFTs. As a result, it was necessary to fully utilise the supply of LFTs available under tender C40441 and then increase the volume of LFTs available under that tender to 713,500,000. This was necessary to ensure continuing supply of LFTs to the public, as any delay would risk the current stock of LFTs being exhausted thereby introducing a significant risk to public health. This modification (in the form of increased volume available under the tender) does not alter the overall nature of the contracts let under the tender process. <br/>In accordance with the allocation mechanism set out in the ITT, and following this modification, UKHSA entered into a contract with Innova Medical Group Inc on 17 December 2021 for the supply of LFTs. This order was made up of volume anticipated under the original tender as well as additional volume available as a result of this modification. The total value of both elements was £322,500,000. The increase in price as a result of the modification does not exceed 50% of the value of the original contracts let under the original tender process.<br/>No further tender process was required to implement this modification because it meets the requirements set out in Regulation 72(1)(c) of the Public Contracts Regulations 2015 for the reasons set out in this notice.

II.2.5) Award criteria

Quality criterion: Social Value / Weighting: 30%

Cost criterion: Price / Weighting: 70%

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Restricted procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

A dynamic purchasing system was set up

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2021/S 000-004511

Section V: Award of contract

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

17/12/2021

V.2.2) Information about tenders

Number of tenders received: 9

Number of tenders received from tenderers from non-EU Member States: 2

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

INNOVA MEDICAL GROUP INC.

800 E. Colorado Blvd., Ste 288, Pasadena, California

Pasadena

91101

US

NUTS: US

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Initial estimated total value of the contract/lot:

Total value of the contract/lot: Lowest offer: 322 500 000.00  GBP / Highest offer: 322 500 000.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.4) Procedures for review

VI.4.1) Review body

The High Court

Strand

London

WC2A 2LL

UK

E-mail: generaloffice@administrativecourtoffice.justice.gov.uk

Internet address(es)

URL: https://www.gov.uk/courts-tribunals

VI.5) Date of dispatch of this notice

17/01/2022

Coding

Commodity categories

ID Title Parent category
33141625 Diagnostic kits Disposable non-chemical medical consumables and haematological consumables

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
Procurement.operations@dhsc.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.